Figure S20 from HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity

Fig. S20. SDS-PAGE of HDAC6 KO cells. MM cells were either untreated or treated with sgRNA scrambled control or sgRNA specific to HDAC6. Following selection, cell lysates were prepared and electrophoresed on SDS gels, transferred to PVDF. Membranes were probed for HDAC6 using a knockout verified antibody (catalog number ab133493, Abcam, Waltham, MA) a dilution of 1:10,000.